My Approach to Diagnosing Systemic Disease
Diagnosing systemic disease requires connecting the dots from the microscope to the bedside, according to Mayo Clinic dermatologist and dermatopathologist Olayemi Sokumbi, MD, FAAD.
In this Next Steps in Derm interview, in partnership with the ODAC Dermatology Conference, Dr. Sokumbi outlines how she makes diagnostic decisions, including thinking beyond the skin. As a dermatologic detective of …
Diagnosing systemic disease requires connecting the dots from the microscope to the bedside, according to Mayo Clinic dermatologist and dermatopathologist Olayemi Sokumbi, MD, FAAD.
In this Next Steps in Derm interview, in partnership with the ODAC Dermatology Conference, Dr. Sokumbi outlines how she makes diagnostic decisions, including thinking beyond the skin. As a dermatologic detective of … Continue reading "My Approach to Diagnosing Systemic Disease"
Baricitinib (Olumiant®) is a once daily oral medication recently FDA approved for severe alopecia areata, which is defined as having a Severity of Alopecia Tool (SALT) score of 50 or higher.1 JAK inhibitors are a relatively new class of drug demonstrating efficacy and safety in a range of inflammatory skin disorders. Emerging studies have highlighted baricitinib’s effectiveness for conditions l … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i …